Canada revised its Interim Federal Health Program on 1 May, introducing co-pays for a range of services provided to asylum claimants, National Post reported. Until then, asylum claimants had received their health-related services free, a benefit that National Post noted was not extended to Canadian citizens. National Post columnist Jamie Sarkonak framed Canada as “the medical resort of the developing world”, a polemical reading of a public-health-financing decision rather than a medical tourism one.
What the asylum co-pays cover
The Carney government in Ottawa announced the revision last autumn, National Post reported, in response to public argument over the cost of the program. Under the previous arrangement asylum claimants received free doctor visits, eye and dental care, physiotherapy and psychotherapy, mobility aids and prescriptions. That coverage often continued even after a refugee claim was refused. The revised policy now asks asylum claimants to pay 30 per cent of the cost of several services, among them eye exams, new glasses, dental care, counselling, physiotherapy and home care. Prescriptions carry a new $4 co-pay.
A second tier of services stays free of charge for asylum claimants. Emergency room visits, doctor visits, hospital stays, surgery, vaccinations, birthing care, scans, tests and X-rays remain fully covered, National Post reported. The co-pays therefore fall on lower-cost outpatient care while the high-cost hospital work is left untouched. That split decides how much money the change can actually recoup.
The billion-dollar projection
The Parliamentary Budget Officer assessed in February that the Interim Federal Health Program was on course to cross $1 billion a year, National Post reported. That same study traced a steep rise in both use and cost of the program between 2016 and 2024. Asylum claimants drawing on it multiplied by seven over those years, and the average outlay per person tripled across the same period. Before the co-pays were introduced, the program was projected to reach $1.5 billion by 2029.
The budget officer’s report did not fold in the financial effect of the new co-pay charges, National Post reported, so the headline projection still describes the program as it ran before 1 May. That gap matters for reading the policy, because the co-pays sit on outpatient services while the sevenfold rise in asylum claimants and the tripling of per-person outlay are driven by the whole caseload. No actuarial estimate of the co-pays’ net effect has yet been published, which leaves the billion-dollar figure unaudited against the new policy.
Fraud and the origin of claims
National Post also reported a single case of fraud inside the program. In March a therapist admitted to double-billing for counselling sessions with asylum seekers and to handing the work to interns, and she was suspended and fined $4,700. National Post presented the case as one instance rather than as a measured rate, and no program-wide figure for fraud was offered.
That same column set out its own account of why asylum claims have risen. It named students from India who claim refugee status once study permits lapse, people from Nigeria who allege persecution on grounds of sexual orientation, former gang members from Mexico and Latin America, and residents of European countries who say police protection at home is insufficient. That list is Sarkonak’s polemical characterisation, and it should be read as the argument of an opinion piece rather than as verified case data.
Why this is not medical tourism
There is a category error at the heart of the medical-resort framing, and it is worth naming plainly. Health tourism runs along a spectrum defined partly by intent, and a medical tourist chooses to travel and to buy care abroad because it is cheaper, faster, better or unavailable at home. An asylum claimant is not making that purchase. Their care follows from where the person already is and from what a domestic program covers, not from a cross-border transaction sold to a paying patient. Folding asylum health provision into the language of medical tourism conflates two flows that behave differently and answer to different levers.
The distinction is not academic for policymakers. A medical tourism market responds to pricing, accreditation and waiting times, and a government can grow it or cool it by adjusting those. A domestic health entitlement for asylum claimants answers instead to immigration policy and to the size of the caseload. Yet the Carney government has reached for the one instrument that treats the entitlement as a market, a co-pay, when the sevenfold rise its budget officer recorded belongs to the caseload. Co-pays on eye exams and physiotherapy recoup money at the margin, and they leave the driver of the projection untouched.
What to watch
This policy faces a measurable and near-term test. Future reports from the Parliamentary Budget Officer will show whether the co-pays bend the cost curve or merely trim outpatient billing. They will also show whether use of the newly charged services, dental, ophthalmic and physiotherapy care among them, falls once a 30 per cent share applies. The origin-of-claims argument will be settled by immigration and refugee data, not by a program that reimburses treatment after arrival. For a government facing a $1.5 billion projection by 2029, the honest question is whether it is managing the cost of the Interim Federal Health Program or the politics around it. The co-pays as designed answer more of the second than the first.
